IP Library › Assignment 033797/0066
Patent Assignment
Reel/Frame 033797/0066

Merger and Change of Name

Recorded: 2014-09-23 Pages: 4
Assignors
METASIGNAL THERAPEUTICS INC.
Executed: 2013-01-14
Assignee
SIGNALCHEM LIFESCIENCES CORPORATION
5600 PARKWOOD WAY, SUITE 550, RICHMOND, BRITISH COLUMBIA, V6V 2M2, CANADA
Covered Properties (3)
Novel Sulfonamide Compounds for Inhibition of Metastatic Tumor Growth
Patent: 9,463,171 →
Application: 13/737,704 →
Publication: US 2013/0190396
Carbonic Anhydrase Inhibitors with Antimetastatic Activity
Application: 14/078,455 →
Publication: US 2014/0148400
Carbonic Anhydrase Ix-Related Markers and Use Thereof
Application: 14/353,665 →
Publication: US 2014/0303103
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 9, 2013
From: SUPURAN, CLAUDIU; DEDHAR, SHOUKAT; MCDONALD, PAUL C.; CARTA, FABRIZIO
To: METASIGNAL THERAPEUTICS INC.
Reel/Frame 030181/0617 →
Assignment of Assignor's Interest Aug 11, 2014
From: MCDONALD, PAUL C.; LOCK, FRANCES E.; DEDHAR, SHOUKAT
To: METASIGNAL THERAPEUTICS INC.; BRITISH COLUMBIA CANCER AGENCY BRANCH
Reel/Frame 033506/0227 →
Assignment of Assignor's Interest Sep 19, 2014
From: WINUM, JEAN-YVES
To: CNRS-DIRE; UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES
Reel/Frame 033782/0305 →
Assignment of Assignor's Interest Sep 19, 2014
From: SUPURAN, CLAUDIU; DEDHAR, SHOUKAT; CARTA, FABRIZIO; MCDONALD, PAUL C.
To: METASIGNAL THERAPEUTICS INC.
Reel/Frame 033782/0309 →
Assignment of Assignor's Interest Oct 8, 2015
From: SIGNALCHEM LIFESCIENCES CORPORATION
To: WELICHEM BIOTECH INC.
Reel/Frame 036761/0460 →